Magellan Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Magellan Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Magellan Health in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.000.000.00
Details
Intrinsic
Valuation
LowReal ValueHigh
1.1923.7523.75
Details
1 Analysts
Consensus
LowTarget PriceHigh
95.0095.0095.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Magellan Health. Your research has to be compared to or analyzed against Magellan Health's peers to derive any actionable benefits. When done correctly, Magellan Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Magellan Health.

Magellan Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Magellan Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Magellan and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Magellan Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Magellan Health Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Magellan Stock performing well and Magellan Health company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Magellan Health's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
LH 1.53  0.03  0.01  0.13  2.07  0.0123 (1.53)  3.41 (3.09)  12.22 
MD 2.30 (0.21)  0.00 (0.07)  0.00 (0.05)  0.00  4.37 (3.90)  25.66 
BUD 1.49  0.25  0.15  0.37  1.53  0.13 (1.80)  3.45 (2.77)  8.01 
ETSY 3.31  0.36  0.10  0.30  3.73  0.09 (3.47)  6.13 (6.32)  20.97 
BUDFF 1.44  0.27  0.13  0.47  1.49  0.12 (1.62)  3.65 (2.86)  7.80 
LIN 1.37  0.19  0.13  0.29  1.24  0.11 (1.57)  3.81 (2.02)  7.54 
DD 1.77  0.29  0.17  0.35  1.45  0.14 (2.09)  3.91 (2.34)  10.00 
BAC 1.54  0.02  0.02  0.12  1.65  0.0196 (1.64)  4.14 (2.87)  9.00 
PG 0.96  0.08  0.03  0.23  1.09  0.0362 (0.98)  1.83 (2.07)  4.27 
AXP 1.75 (0.06) (0.02)  0.05  1.77 (0.0137) (2.14)  3.88 (3.11)  8.22 

Cross Equities Net Income Analysis

Select Fundamental

2010201120122013201420152016201720182019202020212022
LH558.2 M519.7 M583.1 M573.8 M511.2 M436.9 M732.1 M1.3 B883.7 M823.8 M1.6 B2.4 B2.6 B
MD202.7 M218 M240.9 M280.5 M317.3 M336.3 M324.9 M320.4 M268.6 M(1.5 B)(796.5 M)131 M141.3 M
BUD5.8 B5.8 B7.2 B14.4 B9.2 B8.3 B1.2 B7.4 B3.8 B8.7 B(650 M)4.7 B5.1 B
ETSY(2.4 M)(2.4 M)(2.4 M)(796 K)(15.2 M)(54.1 M)(29.9 M)81.8 M77.5 M95.9 M349.2 M493.5 M532.5 M
LIN1.5 B1.5 B1.5 B1.5 B1.5 B1.5 B1.5 B1.2 B4.4 B2.3 B2.5 B3.8 B3.5 B
DD1.2 B1.2 B1.2 B1.2 B1.2 B1.2 B1.2 B1.2 B3.8 B498 M(3 B)6.5 BB
BAC(2.2 B)1.4 B4.2 B11.4 B4.8 B15.9 B17.9 B18.2 B28.1 B27.4 B17.9 B32 B34.5 B
PG12.7 B10.8 B11.3 B11.6 BB10.5 B15.3 B9.8 B3.9 B13 B14.3 B14.7 B12.5 B
AXP4.1 B4.9 B4.5 B5.4 B5.9 B5.2 B5.4 B2.7 B6.9 B6.8 B3.1 B8.1 B6.4 B

Magellan Health and related stocks such as Laboratory, Mednax Inc, Anheuser Busch Inbev, Etsy Inc, Anheuser-Busch InBev SANV, Linde PLC, Dupont De Nemours, Bank Of America, Procter Gamble, and American Express Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Magellan Health financial statement analysis. It represents the amount of money remaining after all of Magellan Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Magellan Health Competitive Analysis

The better you understand Magellan Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Magellan Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Magellan Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LHMDBUDETSYBUDFFLINDDBACPGAXP
 2.14 
 236.39 
Laboratory
 3.75 
 15.67 
Mednax
 1.49 
 59.45 
Anheuser
 2.33 
 137.21 
Etsy
 1.02 
 59.38 
Anheuser-Busch
 0.92 
 334.26 
Linde
 1.59 
 70.42 
Dupont
 4.46 
 34.47 
B of A
 1.01 
 149.09 
Procter
 0.43 
 156.08 
American
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Annual Yield
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Magellan Health Competition Performance Charts

Complement your Magellan Health position

In addition to having Magellan Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rentals Thematic Idea Now

Rentals
Rentals Theme
Companies providing rental and leasing services to public and business. The Rentals theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
View All  Next Launch
Additionally, see Correlation Analysis. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Tools for Magellan Stock

When running Magellan Health price analysis, check to measure Magellan Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Magellan Health is operating at the current time. Most of Magellan Health's value examination focuses on studying past and present price action to predict the probability of Magellan Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Magellan Health's price. Additionally, you may evaluate how the addition of Magellan Health to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Magellan Health competes with Laboratory, Mednax, Anheuser Busch, Etsy, and Anheuser-Busch InBev; as well as few others. The company conducts business under Healthcare sector and is part of Healthcare Plans industry. Analyzing Magellan Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Magellan Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Magellan Health competition on your existing holdings. Additionally, see Correlation Analysis.
  
Magellan Health Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 0.11. Return on Average Equity is expected to rise to 0.23 this year, although the value of Return on Investment will most likely fall to (0.71) . Magellan Health Tax Assets are quite stable at the moment as compared to the past year. The company's current value of Tax Assets is estimated at 1.7 Million. Revenue to Assets is expected to rise to 1.99 this year, although the value of Total Assets will most likely fall to about 3.4 B.